Introduction/Background*Breast cancer is the first women cancer. For adequate treatment we should have a relevant diagnosis based on morphology and immunohistochemistry (IHC). In our national institute of oncology the deadlines of pathology report are very long because of the significant number of samples received from different department. We have established a specific protocol to manage breast biopsy to speed up the histological report. We would represent in this paper the evaluation of the implantation of this support protocol in our lab.

Methodology In the new procedure of our lab the breast biopsy was separately treated from other routine samples. They was treated in cassette of different color. Two technicians was specially dedicate to manage all the technical steps.In our laboratory we received both chirurgical and radiological biopsy. Both go under the same technical protocol. They are fixed with formalin then they goes through the preanalytical procedures the same day. To evaluate the impact of the implement of this procedure, we compare the report output deadline of biopsy received between January and February 2018 with those received the same period in 2020 after the implementation of the protocol.

Result(s)*In 2018, the deadlines of issuing the final report were on average 21.5 day while in 2020 after implementation of the protocol, the deadlines issuing passed to 11.75 day. The deadlines stay long because of many others issues like long absence of patients especially for socio-economic reasons. For us in the laboratory we can guarantee a primary report based on morphological features within 2 days after receiving the biopsy. The final report with IHC report can be ready in maximum 6 days after receiving the sample. In fact it depends on the rhythm of the IHC technique which is programmed minimum twice per week.

Conclusion*Pathology report is the key of all therapeutic issues in breast cancer. For a best supported therapy for our patients we accelerate the procedure of biopsy management while keeping a good quality of study. Our ultimate goal is to provide the most specific diagnosis as soon as possible to procure the best therapy for patients.